Skip to content

Author

M. Merlo

We have 3 of 74 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cardiac magnetic resonance-based prediction of ventricular arrhythmic events in non-ischemic cardiomyopathy: derivation and external validation in the international multicenter IMPROVE-NICM Study

Risk stratification for sudden cardiac death (SCD) in non-ischemic cardiomyopathy (NICM) remains suboptimal. Current guidelines recommend primary prevention implantable cardioverter-defibrillator (ICD) implantation in patients with LVEF <35% (NYHA II–III) (1); however, its limited predictive accuracy (2,3) unders...

A. Latini, G. Falasconi, C. Panico et al. · 0 citations
Oct 2026

Impact of genetic testing on primary prevention ICD decision-making and clinical outcomes in dilated cardiomyopathy

Despite advances in clinical risk stratification, dilated cardiomyopathy (DCM) remains associated with a substantial risk of malignant ventricular arrhythmias and sudden cardiac death. Genetic testing may provide incremental value in arrhythmic risk assessment and primary prevention implantable cardioverter-defib...

A. Bernabei, A. Paldino, A. Fluca et al. · 0 citations
Open access Oct 2026

Clinical predictors for ventricular arrhythmia and heart failure hospitalisation in cardiac sarcoidosis

Ventricular arrhythmia (VA) and heart failure (HF) hospitalisation are major adverse outcomes in patients with cardiac sarcoidosis (CS). We aimed to identify clinical, laboratory and imaging predictors on the outcomes of these patients. 572 patients with a definite or probable diagnosis of CS according to...

V. Rossi, S. Anchise, G. Tersalvi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.